The impact of chromosomal fusions on 3D genome

The influence of chromosomal fusions on 3D genome folding and recombination within the germ line
The spatial folding of chromosomes contained in the nucleus has regulatory results on gene expression, but the influence of genome reshuffling on this group stays unclear. Right here, we make the most of chromosome conformation seize together with single-nucleotide polymorphism (SNP) genotyping and evaluation of crossover occasions to review how the higher-order chromatin group and recombination landscapes are affected by chromosomal fusions within the mammalian germ line.
We exhibit that chromosomal fusions alter the nuclear structure throughout meiosis, together with an elevated price of heterologous interactions in main spermatocytes, and alterations in each chromosome synapsis and axis size.
These disturbances in topology have been related to modifications in genomic landscapes of recombination, leading to detectable genomic footprints. General, we present that chromosomal fusions influence the dynamic genome topology of germ cells in two methods: (i) altering chromosomal nuclear occupancy and synapsis, and (ii) reshaping landscapes of recombination.

Profiles of immune cell infiltration and immune-related genes within the tumor microenvironment of HNSCC with or with out HPV an infection

Head and neck squamous cell carcinoma (HNSCC) are the sixth commonest most cancers sort on this planet. Human papillomavirus (HPV) an infection is an rising threat issue for HNSCC. Immune infiltration of HNSCC is linked to therapeutic outcomes. This text aimed to determine whether or not variations in HPV standing have an effect on immune infiltration, molecular mechanism, and the way these outcomes fluctuate in HNSCC sufferers.
We investigated the tumor-infiltrating immune cells (TIICs) and immune-related gene variations between HPV (+) and HPV (-) HNSCC. The gene expression quantification information of HNSCC and their medical data have been obtain from the TCGA database. Immune-related genes have been linked to the ImmPort platform.
After analyzed of 22 TIICs within the HNSCC tumor atmosphere by CIBERSORT and additional evaluation, decrease reminiscence B cell and better T cell regulatory have been related with higher HPV (-) HNSCC end result, increased activated reminiscence CD4 T cell, increased T cell regulatory, and decrease activated NK cell have been linked with higher HPV (+) consequence.
We lastly acquired 5 types of immune genes (CAMP, EDNRB, NTS, CXCL9, LHB) related to HNSCC development. Larger expressions of CAMP, EDNRB, and NTS have been related to elevated total survival in HPV (-) sufferers. Larger expression of CXCL9 and decrease expression of LHB contributed to elevated total survival of HPV (+) sufferers.
There are typically discrepancies within the cell construction of TIICs and immune-related genes in HPV (-) and HPV (+) HNSCC. These variances are usually too essential for the therapeutic end result of the affected person and the event of the tumor. In particular, our pattern established these candidate immune cells and immune-related genes as candidate reservoirs for additional researches.
x-dv
x-dv

DiscoveryProbe? Kinase Inhibitor Library

L1024-.1 100 uL/well(10 mM solution)
EUR 6267

IKK-? Kinase Inhibitor II

1811-1
EUR 158

VEGFR Tyrosine Kinase Inhibitor II

C4603-1 1 mg
EUR 118

DiscoveryProbe? Tyrosine Kinase Inhibitor Library

L1028-.1 100 uL/well(10 mM solution)
EUR 5397

ET-1/ Rat ET- 1 ELISA Kit

ELA-E0482r 96 Tests
EUR 886

Kinase inhibitor-1

HY-43533 5mg
EUR 567

HPGDS inhibitor 1

B1046-1 1 mg
EUR 181
Description: HPGDS inhibitor 1 is an oral potent and selective inhibitor of hematopoietic prostaglandin D synthase (HPGDS) with IC50 value of 0.7nM [1].Prostaglandin D2 (PGD2) is a mediator of allergy and inflammation.

TAO Kinase inhibitor 1

HY-112136 50mg
EUR 796

MAPKII Kinase Inhibitor (Hsp25 Kinase Inhibitor)

SIH-120A 1 mg
EUR 179
Description: The substance MAPKII Kinase Inhibitor is a hsp25 kinase inhibitor. It is synthetically produced and has a purity of >95%. The pure substance is white solid which is soluble in DMSO or H20.

ET-1 Polyclonal Antibody

ES3877-100ul 100ul
EUR 279
Description: A Rabbit Polyclonal antibody against ET-1 from Human. This antibody is tested and validated for WB, ELISA, WB, ELISA

ET-1 Polyclonal Antibody

ES3877-50ul 50ul
EUR 207
Description: A Rabbit Polyclonal antibody against ET-1 from Human. This antibody is tested and validated for WB, ELISA, WB, ELISA

ET-1 Polyclonal Antibody

ABP52878-003ml 0.03ml
EUR 158
Description: A polyclonal antibody for detection of ET-1 from Human. This ET-1 antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human ET-1

ET-1 Polyclonal Antibody

ABP52878-01ml 0.1ml
EUR 289
Description: A polyclonal antibody for detection of ET-1 from Human. This ET-1 antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human ET-1

ET-1 Polyclonal Antibody

ABP52878-02ml 0.2ml
EUR 414
Description: A polyclonal antibody for detection of ET-1 from Human. This ET-1 antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human ET-1

Anti-ET-1 antibody

STJ96512 200 µl
EUR 197
Description: Rabbit polyclonal to ET-1.

ET-1 Polyclonal Antibody

41562-100ul 100ul
EUR 252

ET-1 Polyclonal Antibody

41562-50ul 50ul
EUR 187

Endothelin 1 (ET-1) Antibody

abx024086-100ug 100 ug
EUR 940

Sorafenib (Raf-1 kinase inhibitor)

SIH-476-10MG 10 mg
EUR 121
Description: The substance Sorafenib is a raf-1 kinase inhibitor. It is synthetically produced and has a purity of >99%. The pure substance is off white powder which is soluble inDMSO (200mg/ml) or ethanol (3mg/ml).

Sorafenib (Raf-1 kinase inhibitor)

SIH-476-50MG 50 mg
EUR 289
Description: The substance Sorafenib is a raf-1 kinase inhibitor. It is synthetically produced and has a purity of >99%. The pure substance is off white powder which is soluble inDMSO (200mg/ml) or ethanol (3mg/ml).

187-1, N-WASP inhibitor

B5251-1 1 mg
EUR 399

p16-INK4a Cyclin-Dependent Kinase Inhibitor 2A Human Recombinant Protein

PROTP42771-1 Regular: 20ug
EUR 317
Description: CDKN2A Human Recombinant produced in E.Coli, it's a single non-glycosylated polypeptide chain containing 156 amino acids, approximately 16.5 kDa.;CDKN2A is purified by proprietary chromatographic techniques.

Mouse ET-1 ELISA Kit

EME0184 96Tests
EUR 521

Porcine ET-1 ELISA Kit

EPE0184 96Tests
EUR 521

Rat ET-1 ELISA Kit

ERE0184 96Tests
EUR 521

Rabbit ET-1 ELISA Kit

ERTE0184 96Tests
EUR 521

Anserini ET-1 ELISA Kit

EAE0184 96Tests
EUR 521

Goat ET-1 ELISA Kit

EGTE0184 96Tests
EUR 521

Canine ET-1 ELISA Kit

ECE0184 96Tests
EUR 521

Human ET-1 ELISA Kit

EHE0184 96Tests
EUR 521

Bovine ET-1 ELISA Kit

EBE0184 96Tests
EUR 521

ET-1 Polyclonal Conjugated Antibody

C41562 100ul
EUR 397

Canine ET-1 ELISA Kit

ELA-E0482d 96 Tests
EUR 928

ET-1(Endothelin-1) ELISA Kit

EU0205 96T
EUR 524.1
Description: Method of detection: Coated with Antigen, Competitive ELISA;Reacts with: General;Sensitivity: 0.625pg/ml

Big ET/ Rat Big ET ELISA Kit

ELA-E0483r 96 Tests
EUR 886

YAP-TEAD Inhibitor 1 (Peptide 17)

A1149-1 1 mg
EUR 235

AKT Kinase Inhibitor

HY-10249A 10mg
EUR 877

Tyrosine kinase inhibitor

HY-10421 25mg
EUR 383

Tie2 kinase inhibitor

E1KS1577 10mg
EUR 1541

MAPKII Kinase Inhibitor

abx076811-1mg 1 mg
EUR 314

AKT Kinase Inhibitor

A3150-10 10 mg
EUR 1136
Description: AKT Kinase Inhibitor

AKT Kinase Inhibitor

A3150-5 5 mg
EUR 683
Description: AKT Kinase Inhibitor

AKT Kinase Inhibitor

A3150-5.1 10 mM (in 1mL DMSO)
EUR 746
Description: AKT Kinase Inhibitor

Dasatinib (Kinase inhibitor)

SIH-440-25MG 25 mg
EUR 199
Description: The substance Dasatinib is a kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is crystalline solid which is soluble in DMSO (200 mg/ml), ethanol (very poorly ), and water (very poorly ).

Dasatinib (Kinase inhibitor)

SIH-440-5MG 5 mg
EUR 134
Description: The substance Dasatinib is a kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is crystalline solid which is soluble in DMSO (200 mg/ml), ethanol (very poorly ), and water (very poorly ).

K252A (Kinase inhibitor)

SIH-455-100UG 100 µg
EUR 131
Description: The substance K252A is a kinase inhibitor. It is nonomuraea longicatena and has a purity of ?98%. The pure substance is white solid which is soluble to 25 mM in DMSO.

K252A (Kinase inhibitor)

SIH-455-1MG 1 mg
EUR 299
Description: The substance K252A is a kinase inhibitor. It is nonomuraea longicatena and has a purity of ?98%. The pure substance is white solid which is soluble to 25 mM in DMSO.

K252B (Kinase inhibitor)

SIH-456-100UG 100 µg
EUR 182
Description: The substance K252B is a kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is white solid which is soluble in DMSO (1 mg/ml) or dimethyl formamide (1 mg/ml).

K252B (Kinase inhibitor)

SIH-456-1MG 1 mg
EUR 569
Description: The substance K252B is a kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is white solid which is soluble in DMSO (1 mg/ml) or dimethyl formamide (1 mg/ml).

Midostaurin (Kinase inhibitor)

SIH-468-1MG 1 mg
EUR 171
Description: The substance Midostaurin is a kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is white to off-white powder which is soluble in DMSO (15 mg/ml), MDC (10 mg/ml), methanol (5 mg/ml) or 100% ethanol (2.5 mg/ml).

Midostaurin (Kinase inhibitor)

SIH-468-5MG 5 mg
EUR 507
Description: The substance Midostaurin is a kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is white to off-white powder which is soluble in DMSO (15 mg/ml), MDC (10 mg/ml), methanol (5 mg/ml) or 100% ethanol (2.5 mg/ml).

Tie2 kinase inhibitor

A5979-100 100 mg
EUR 1210
Description: IC50: A reversible and selective inhibitor of Tie2 with IC50 of 0.25 M, whose selectivity is 200-fold higher than that of p38.

Tie2 kinase inhibitor

A5979-25 25 mg
EUR 398
Description: IC50: A reversible and selective inhibitor of Tie2 with IC50 of 0.25 M, whose selectivity is 200-fold higher than that of p38.

Tie2 kinase inhibitor

A5979-5 5 mg
EUR 166
Description: IC50: A reversible and selective inhibitor of Tie2 with IC50 of 0.25 M, whose selectivity is 200-fold higher than that of p38.

Tie2 kinase inhibitor

A5979-5.1 10 mM (in 1mL DMSO)
EUR 447
Description: IC50: A reversible and selective inhibitor of Tie2 with IC50 of 0.25 M, whose selectivity is 200-fold higher than that of p38.

Tie2 Kinase Inhibitor

B1338-25
EUR 756

Tie2 Kinase Inhibitor

B1338-5
EUR 262

p21/Cyclin-Dependent Kinase Inhibitor 1

MO47036 100 ul
EUR 349

Lck Inhibitor

A3539-1 1 mg
EUR 154
Description: Lck Inhibitor is a small-molecule inhibitor of with IC50 value of 7 nM [1].The lymphocyte specific kinase which expressed in NK cells and T-cells is a member of the Src kinase family.

NFAT Inhibitor

A4539-1 1 mg
EUR 138
Description: Selective inhibitor of calcineurin-mediated dephosphorylation of nuclear factor of activated T cells (NFAT). Does not disrupt other calcineurin-dependent pathways. Inhibits NFAT activation and NFAT-dependent expression of endogenous cytokine genes in T cells.

EGFR Inhibitor

C3327-1 1 mg
EUR 154
Description: EGFR inhibitor is a cell permeable, pyrimidine compound that selectively inhibits the EGFR kinase with IC50 value of 21 nM [1]. EGFR is a transmembrane protein, and is a receptor for members of epidermal growth factor family.

Stat5 Inhibitor

9484-1
EUR 120

Chk2 Inhibitor

1702-1
EUR 180

SCD1 Inhibitor

1716-1
EUR 218

ACC2 Inhibitor

1717-1
EUR 218

Syk Inhibitor

1983-1
EUR 126

Phosphatase Inhibitor Cocktail 1 (100X in DMSO)

K1012-1 1 ml
EUR 102

ET-3 antibody

22579-100ul 100ul
EUR 390

ET-2 Antibody

35400-100ul 100ul
EUR 390

Rabbit Endothelin 1,ET-1 ELISA Kit

GA-E0074RB-48T 48T
EUR 326

Rabbit Endothelin 1,ET-1 ELISA Kit

GA-E0074RB-96T 96T
EUR 524

Canine Endothelin 1(ET-1)ELISA Kit

GA-E0098CN-48T 48T
EUR 402

Canine Endothelin 1(ET-1)ELISA Kit

GA-E0098CN-96T 96T
EUR 684

Mouse Endothelin 1(ET-1)ELISA Kit      

GA-E0270MS-48T 48T
EUR 336

Mouse Endothelin 1(ET-1)ELISA Kit      

GA-E0270MS-96T 96T
EUR 534

Rat Endothelin 1(ET-1)ELISA Kit

GA-E0470RT-48T 48T
EUR 317

Rat Endothelin 1(ET-1)ELISA Kit

GA-E0470RT-96T 96T
EUR 496

Human Endothelin 1(ET-1)ELISA Kit

GA-E1255HM-48T 48T
EUR 289

Human Endothelin 1(ET-1)ELISA Kit

GA-E1255HM-96T 96T
EUR 466

human Endothelin 1,ET-1 ELISA Kit

201-12-1239 96 tests
EUR 440
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids.

Human Endothelin 1 (ET-1) CLIA Kit

abx195560-96tests 96 tests
EUR 825

Mouse Endothelin 1 (ET-1) CLIA Kit

abx195561-96tests 96 tests
EUR 825

Rat Endothelin 1 (ET-1) CLIA Kit

abx195562-96tests 96 tests
EUR 825

Porcine ET-1(Endothelin 1) ELISA Kit

EP0049 96T
EUR 567.6
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Pig;Sensitivity: 0.625pg/ml

Rat ET-1(Endothelin 1) ELISA Kit

ER0019 96T
EUR 524.1
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Rattus;Sensitivity: 4.688pg/ml

Mouse Endothelin 1, ET-1 ELISA Kit

CSB-E05145m-24T 1 plate of 24 wells
EUR 165
Description: Quantitativesandwich ELISA kit for measuring Mouse Endothelin 1, ET-1 in samples from serum, plasma, cell culture supernates. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price.

Mouse Endothelin 1, ET-1 ELISA Kit

1-CSB-E05145m
  • EUR 946.00
  • EUR 5782.00
  • EUR 3060.00
  • 1 plate of 96 wells
  • 10 plates of 96 wells each
  • 5 plates of 96 wells each
Description: Quantitativesandwich ELISA kit for measuring Mouse Endothelin 1, ET-1 in samples from serum, plasma, cell culture supernates. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits.

Pig endothelin 1, ET-1 ELISA Kit

CSB-E06806p-24T 1 plate of 24 wells
EUR 165
Description: Quantitativesandwich ELISA kit for measuring Pig endothelin 1, ET-1 in samples from serum, plasma, tissue homogenates. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price.

Pig endothelin 1, ET-1 ELISA Kit

1-CSB-E06806p
  • EUR 804.00
  • EUR 5099.00
  • EUR 2704.00
  • 1 plate of 96 wells
  • 10 plates of 96 wells each
  • 5 plates of 96 wells each
Description: Quantitativesandwich ELISA kit for measuring Pig endothelin 1, ET-1 in samples from serum, plasma, tissue homogenates. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits.

Rabbit Endothelin 1, ET-1 ELISA Kit

CSB-E06951Rb-24T 1 plate of 24 wells
EUR 165
Description: Quantitativesandwich ELISA kit for measuring Rabbit Endothelin 1, ET-1 in samples from serum, plasma, tissue homogenates. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price.

Rabbit Endothelin 1, ET-1 ELISA Kit

1-CSB-E06951Rb
  • EUR 967.00
  • EUR 5925.00
  • EUR 3134.00
  • 1 plate of 96 wells
  • 10 plates of 96 wells each
  • 5 plates of 96 wells each
Description: Quantitativesandwich ELISA kit for measuring Rabbit Endothelin 1, ET-1 in samples from serum, plasma, tissue homogenates. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits.

rat Endothelin 1, ET-1 ELISA Kit

CSB-E06979r-24T 1 plate of 24 wells
EUR 165
Description: Quantitativesandwich ELISA kit for measuring rat Endothelin 1, ET-1 in samples from serum, plasma, cell lysates, tissue homogenates. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price.

Multi-ancestry genome-wide affiliation examine identifies 27 loci related to measures of hemolysis following blood storage

The evolutionary strain of endemic malaria and different erythrocytic pathogens has formed variation in genes encoding erythrocyte structural and purposeful proteins, influencing responses to hemolytic stress throughout transfusion and illness.
We sought to determine such genetic variants in blood donors by conducting a genome-wide affiliation examine (GWAS) of 12,353 volunteer donors, together with 1,483 African People, 1,477 Asians, and 960 Hispanics, whose saved erythrocytes have been characterised by quantitative assays of in vitro osmotic, oxidative, and cold-storage hemolysis.
GWAS revealed 27 important loci (p<5×10-8), many in candidate genes identified to modulate erythrocyte construction, metabolism, and ion channels, together with SPTA1, ALDH2, ANK1, HK1, MAPKAPK5, AQP1, PIEZO1, and SLC4A1/Band 3. GWAS of oxidative hemolysis recognized variants in antioxidant enzymes together with GLRX, GPX4, G6PD, and a novel golgi-transport protein SEC14L4.
Genome extensive important loci have been additionally examined for affiliation with the severity of regular state (baseline) in vivo hemolytic anemia in sufferers with sickle cell illness, with affirmation of recognized SNPs in HBA2, G6PD, PIEZO1, AQP1 and SEC14L4. Most of the recognized variants, equivalent to these in G6PD, have beforehand been proven to impair erythrocyte restoration after transfusion, affiliate with anemia, or trigger uncommon Mendelian human hemolytic illnesses.
Candidate SNPs in these genes, particularly in polygenic combos, could have an effect on RBC restoration after transfusion and modulate illness severity in hemolytic illnesses, equivalent to sickle cell illness and malaria.

Incorporating Genomic and Genetic Testing into the Therapy of Metastatic Luminal Breast Most cancers

Background: Therapy of sufferers with luminal metastatic breast most cancers (MBC) has turn out to be much more complicated over the previous few years as molecular profiling has begun to change illness administration. It’s properly accepted that MBC will not be curable however is treatable. Right now we’re capable of delay progression-free survival and partly total survival with focused and extra particular person therapy methods adjusted in keeping with the molecular subtype.
Abstract: Genetic and genomic testing has turn out to be therapeutically related in luminal MBC and is due to this fact an integral part inside the therapy spectrum. By now, germline testing of BRCABRCAPIK3CA mutations are inevitable parts in illness administration and the present state-of-the-art in luminal MBC sufferers.
Moreover, testing of ESR1 resistance mutation, ERBB2 mutation, microsatellite instability, and neurotrophic tyrosine receptor kinase (NTRK) gene fusion (primarily in secretory breast most cancers) has just lately gained growing consideration. Nonetheless, primarily based on the increasing function of personalised medication, clinicians are actually confronted with substantial new challenges and presumably unsuspected potentialities. The next evaluation summarizes present developments in genetic and genomic testing in luminal MBC.
Key messages: In luminal MBC genomics have turn out to be an integral part inside the spectrum of oncological therapy establishing novel therapeutic services. Additional developments in therapy personalization adjusted in keeping with the molecular subtype ought to turn out to be more and more necessary as a way to improve the progress of de-escalation of chemotherapy in luminal MBC. Nonetheless, primarily based on the increasing function of personalised medication, clinicians are actually confronted with substantial new challenges and presumably unsuspected potentialities.

HIV-1 p24 ELISA Kit

Z7040001 1 kit
EUR 812
Description: Premade ready to use kits will always come in handy. Get your experiment done right form the first try by using a validated kit with perfectly balanced reagents proportions and compatibility and by following a clear protocol.

HIV-1 p24

E5-00024 1mg
EUR 960

HIV-1 p24

E62H002 100ug
EUR 382

HIV Type 1 p24 Antigen ELISA (96 Determinations)

0801111 96T
EUR 548.16
Description: Please contact Gentaur in order to receive the datasheet of the product.

HIV Type 1 p24 Antigen ELISA 2.0 (96 Determinations)

0801002 96T
EUR 548.16
Description: Please contact Gentaur in order to receive the datasheet of the product.

HIV type 1 P24

DAG1520 100 µg
EUR 810

HIV-1 p24 Antibody

20-abx137062
  • EUR 356.00
  • EUR 523.00
  • 0.5 mg
  • 1 mg

Recombinant HIV-1 p24

7-07603 100µg Ask for price

Recombinant HIV-1 p24

7-07604 500µg Ask for price

Recombinant HIV-1 p24

7-07605 1000µg Ask for price

HIV 1 p24 Protein

abx060589-1mg 1 mg
EUR 1288

HIV-1 p24 Protein

abx061424-05mg 0.5 mg
EUR 739

HIV-1, p24 Protein

abx069857-1mg 1 mg
EUR 1574

HIV-1 p24 Antibody

abx021869-1mg 1 mg
EUR 662

HIV-1 p24 Antibody

abx021870-1mg 1 mg
EUR 634

HIV-1 p24 Antibody

abx021871-1mg 1 mg
EUR 662

HIV-1 p24 Antibody

abx021872-1mg 1 mg
EUR 662

HIV-1 p24 Antibody

abx021873-1mg 1 mg
EUR 662

HIV-1 p24 Antibody

abx021882-1mg 1 mg
EUR 982

HIV-1 p24 Antibody

abx021883-1mg 1 mg
EUR 1017

HIV-1 p24 Antibody

abx021886-1mg 1 mg
EUR 1017

HIV-1 p24 Antibody

abx021887-1mg 1 mg
EUR 1017

HIV-1 p24 Antibody

abx021888-1mg 1 mg
EUR 1017

HIV-1 p24 Antibody

abx023027-1ml 1 ml
EUR 578

HIV-1 p24 Antibody

abx023925-1mg 1 mg
EUR 690

HIV-1 p24 Antibody

abx023926-1mg 1 mg
EUR 690

HIV-1 p24 Protein

abx169032-1mg 1 mg
EUR 551

HIV-1 p24 Protein

20-abx261886
  • EUR 4490.00
  • EUR 328.00
  • EUR 230.00
  • 1 mg
  • 20 ug
  • 5 ug

HIV-1 Gag p24

05-005 50 ug
EUR 362
Description: The HIV-1 Gag p24 is available in Europe and for worldwide shipping via Gentaur.

HIV-1 Gag p24

05-006 250 ug
EUR 962
Description: The HIV-1 Gag p24 is available in Europe and for worldwide shipping via Gentaur.

HIV-1 p24 Antibody

7313-002mg 0.02 mg
EUR 171.82
Description: HIV-1 p24 Antibody: The human immunodeficiency virus type 1 (HIV-1) particle consists of an envelope, a core and the region between the two termed matrix. The HIV-1 Gag protein is a late structural protein that contains four proteins: matrix (p17), capsid (p24), nucleocapsid (p7) and the p6 protein. The p24 is the major capsid protein of the virus and has been used in clinical trials as one of the components of the HIV-1 vaccine because of the high degree of sequence conservation between different strains.

HIV-1 p24 Antibody

7313-01mg 0.1 mg
EUR 436.42
Description: HIV-1 p24 Antibody: The human immunodeficiency virus type 1 (HIV-1) particle consists of an envelope, a core and the region between the two termed matrix. The HIV-1 Gag protein is a late structural protein that contains four proteins: matrix (p17), capsid (p24), nucleocapsid (p7) and the p6 protein. The p24 is the major capsid protein of the virus and has been used in clinical trials as one of the components of the HIV-1 vaccine because of the high degree of sequence conservation between different strains.

p24-HIV(p24/661) Antibody

BNCA0661-250 250uL
EUR 383
Description: Primary antibody against p24-HIV(p24/661), APC conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody

BNCAP0661-100 100uL
EUR 199
Description: Primary antibody against p24-HIV(p24/661), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody

BNCAP0661-500 500uL
EUR 544
Description: Primary antibody against p24-HIV(p24/661), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody

BNC810661-100 100uL
EUR 199
Description: Primary antibody against p24-HIV(p24/661), CF680R conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody

BNC810661-500 500uL
EUR 544
Description: Primary antibody against p24-HIV(p24/661), CF680R conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody

BNC880661-100 100uL
EUR 199
Description: Primary antibody against p24-HIV(p24/661), CF488A conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody

BNC880661-500 500uL
EUR 544
Description: Primary antibody against p24-HIV(p24/661), CF488A conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody

BNCB0661-100 100uL
EUR 199
Description: Primary antibody against p24-HIV(p24/661), Biotin conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody

BNCB0661-500 500uL
EUR 544
Description: Primary antibody against p24-HIV(p24/661), Biotin conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody

BNC550661-100 100uL
EUR 199
Description: Primary antibody against p24-HIV(p24/661), CF555 conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody

BNC550661-500 500uL
EUR 544
Description: Primary antibody against p24-HIV(p24/661), CF555 conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody

BNC430661-100 100uL
EUR 199
Description: Primary antibody against p24-HIV(p24/661), CF543 conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody

BNC430661-500 500uL
EUR 544
Description: Primary antibody against p24-HIV(p24/661), CF543 conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody

BNC470661-100 100uL
EUR 199
Description: Primary antibody against p24-HIV(p24/661), CF647 conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody

BNC470661-500 500uL
EUR 544
Description: Primary antibody against p24-HIV(p24/661), CF647 conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody

BNC940661-100 100uL
EUR 199
Description: Primary antibody against p24-HIV(p24/661), CF594 conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody

BNC940661-500 500uL
EUR 544
Description: Primary antibody against p24-HIV(p24/661), CF594 conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody

BNCP0661-250 250uL
EUR 383
Description: Primary antibody against p24-HIV(p24/661), PerCP conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody

BNC040661-100 100uL
EUR 199
Description: Primary antibody against p24-HIV(p24/661), CF405S conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody

BNC040661-500 500uL
EUR 544
Description: Primary antibody against p24-HIV(p24/661), CF405S conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody

BNC050661-100 100uL
EUR 199
Description: Primary antibody against p24-HIV(p24/661), CF405M conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody

BNC050661-500 500uL
EUR 544
Description: Primary antibody against p24-HIV(p24/661), CF405M conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody

BNCR0661-250 250uL
EUR 383
Description: Primary antibody against p24-HIV(p24/661), RPE conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody

BNUB0661-100 100uL
EUR 209
Description: Primary antibody against p24-HIV(p24/661), Concentration: 0.2mg/mL

p24-HIV(p24/661) Antibody

BNUB0661-500 500uL
EUR 458
Description: Primary antibody against p24-HIV(p24/661), Concentration: 0.2mg/mL

p24-HIV(p24/661) Antibody

BNC680661-100 100uL
EUR 199
Description: Primary antibody against p24-HIV(p24/661), CF568 conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody

BNC680661-500 500uL
EUR 544
Description: Primary antibody against p24-HIV(p24/661), CF568 conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody

BNC700661-100 100uL
EUR 199
Description: Primary antibody against p24-HIV(p24/661), CF770 conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody

BNC700661-500 500uL
EUR 544
Description: Primary antibody against p24-HIV(p24/661), CF770 conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody

BNC400661-100 100uL
EUR 199
Description: Primary antibody against p24-HIV(p24/661), CF640R conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody

BNC400661-500 500uL
EUR 544
Description: Primary antibody against p24-HIV(p24/661), CF640R conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody

BNC610661-100 100uL
EUR 199
Description: Primary antibody against p24-HIV(p24/661), CF660R conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody

BNC610661-500 500uL
EUR 544
Description: Primary antibody against p24-HIV(p24/661), CF660R conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody

BNC800661-100 100uL
EUR 199
Description: Primary antibody against p24-HIV(p24/661), CF680 conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody

BNC800661-500 500uL
EUR 544
Description: Primary antibody against p24-HIV(p24/661), CF680 conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody

BNCH0661-100 100uL
EUR 199
Description: Primary antibody against p24-HIV(p24/661), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody

BNCH0661-500 500uL
EUR 544
Description: Primary antibody against p24-HIV(p24/661), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

p24-HIV(p24/661) Antibody

BNUM0661-50 50uL
EUR 395
Description: Primary antibody against p24-HIV(p24/661), 1mg/mL

HIV p24 Antibody

abx021867-1mg 1 mg
EUR 1344

HIV p24 Antibody

abx021868-1mg 1 mg
EUR 1344

Human(HIV-P24)

QY-E05679 96T
EUR 361

HIV Type 1 p24 Antigen ELISA (5 X 96 Determinations)

0801200 5 X 96T
EUR 2119.6
Description: Please contact Gentaur in order to receive the datasheet of the product.

HIV type 1 P24 [GST]

DAG1516 100 µg
EUR 645

HIV type 1 P24 [His]

DAG1518 100 µg
EUR 645

HIV type 1 P24 [Biotin]

DAG1519 100 µg
EUR 810

HIV type 1 P24 [His]

DAG1799 50 ug
EUR 1681

HIV type 1 P24 [His]

DAG2375 100 µg
EUR 724

HIV type 1 P24 [His]

DAG2377 100 µg
EUR 724

HIV type 1 p24 [FITC]

DAGH004 50 Tests
EUR 927

HIV-1 p24, His tag

E410A26-20 20μg
EUR 434

Recombinant HIV-1 p24 Core

7-07597 100µg Ask for price

Recombinant HIV-1 p24 Core

7-07598 500µg Ask for price

Recombinant HIV-1 p24 Core

7-07599 1000µg Ask for price

Recombinant HIV-1 p24 , 24kDa

7-07621 2µg Ask for price

Recombinant HIV-1 p24 , 24kDa

7-07622 10µg Ask for price

Recombinant HIV-1 p24 , 24kDa

7-07623 100µg Ask for price

HIV 1 / 2 p24 Antibody

abx021866-1mg 1 mg
EUR 1010

HIV-1 p24 Antibody (FITC)

abx021884-100ug 100 ug
EUR 739

Add a Comment

Your email address will not be published.